| Jill Mcgarry, CNM | |
|
170 Hazard Ave, Enfield, CT 06082 | |
| (860) 763-4001 | |
| (860) 749-5592 |
| Full Name | Jill Mcgarry |
|---|---|
| Gender | Female |
| Speciality | Advanced Practice Midwife |
| Location | 170 Hazard Ave, Enfield, Connecticut |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649359266 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | 000028 (Connecticut) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jill Mcgarry, CNM 170 Hazard Ave, Enfield, CT 06082 Ph: (860) 763-4001 | Jill Mcgarry, CNM 170 Hazard Ave, Enfield, CT 06082 Ph: (860) 763-4001 |
News Archive
Senesco Technologies, Inc. announced today that a high level of tumor eradication in a mouse model of human multiple myeloma was achieved with a combination of SNS01-T and lenalidomide.
Recently a team of researchers from Saudi Arabia, the United Arab Emirates, and the United States assessed travel-related anxiety in healthcare workers (HCWs) considering the emergence of new variants caused by SARS-CoV-2 mutations.
As the global population ages, the rate of dementia is increasing worldwide. Given that early detection is critical for treatment, effective ways to screen for dementia are a high research priority.
EnzymeRx, LLC (www.enzymerx.com), a clinical-stage biotechnology company, announced that it has launched its first clinical study of Uricase-PEG 20. Subjects have begun enrolling in a phase 1 safety, pharmacokinetic and pharmacodynamic study of single intravenous doses of Uricase-PEG 20.
› Verified 9 days ago
Pamela S. Haskins, LNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 9 Cranbrook Blvd, 2nd Floor, Enfield, CT 06082 Phone: 860-253-5330 Fax: 860-253-5331 |